Durations of therapy for common infections have historically been driven by habits and cultural norms rather than robust scientific data
There is accumulating evidence that shorter durations are equal to longer durations with less antibiotic-associated harm
These recommendations may not apply to immunocompromised patients such as those with HIV, neutropenia, organ transplant, or hematopoietic cell transplant
Guidelines